chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Oropharyngeal pain, Pruritus
Clinical narrative: sore throat; Itchiness; hives; Headaches; Tiredness; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches) and FATIGUE (Tiredness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches), FATIGUE (Tiredness), NAUSEA (nausea) and VOMITING (vomiting). On 28-Mar-2021, OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches), FATIGUE (Tiredness), NAUSEA (nausea) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria, Vomiting
Clinical narrative: sore throat; Itchiness; hives; Headaches; Tiredness; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches) and FATIGUE (Tiredness) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches), FATIGUE (Tiredness), NAUSEA (nausea) and VOMITING (vomiting). On 28-Mar-2021, OROPHARYNGEAL PAIN (sore throat), PRURITUS (Itchiness), URTICARIA (hives), HEADACHE (Headaches), FATIGUE (Tiredness), NAUSEA (nausea) and VOMITING (vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Headache, Nausea, Rash
Clinical narrative: As of now, she still doesn't feel 100%; After 5 days, her left arm at injection site swelled up; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Later on same day, she had headache; She had nausea; She had Rash; She felt dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (As of now, she still doesn't feel 100%), DIZZINESS (She felt dizzy), VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm) and HEADACHE (Later on same day, she had headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0481A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atrial fibrillation, Depression and Cholesterol. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Mar-2021, the patient experienced DIZZINESS (She felt dizzy), HEADACHE (Later on same day, she had headache), NAUSEA (She had nausea) and RASH (She had Rash). On 20-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE SWELLING (After 5 days, her left arm at injection site swelled up), VACCINATION SITE PAIN (Injection site was painful, hard to touch, and itchy and warm) and VACCINATION SITE PRURITUS (Injection site was painful, hard to touch, and itchy and warm). On 29-Mar-2021, the patient experienced DISCOMFORT (As of now, she still doesn't feel 100%). At the time of the report, DISCOMFORT (As of now, she still doesn't feel 100%), DIZZINESS (She felt dizzy), VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm), HEADACHE (Later on same day, she had headache), NAUSEA (She had nausea), RASH (She had Rash), VACCINATION SITE SWELLING (After 5 days, her left arm at injection site swelled up), VACCINATION SITE PAIN (Injection site was painful, hard to touch, and itchy and warm) and VACCINATION SITE PRURITUS (Injection site was painful, hard to touch, and itchy and warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included A-fib medication, anti-depressant and cholesterol medication. Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: As of now, she still doesn't feel 100%; After 5 days, her left arm at injection site swelled up; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Injection site was painful, hard to touch, and itchy and warm; Later on same day, she had headache; She had nausea; She had Rash; She felt dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (As of now, she still doesn't feel 100%), DIZZINESS (She felt dizzy), VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm) and HEADACHE (Later on same day, she had headache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0481A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Atrial fibrillation, Depression and Cholesterol. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 15-Mar-2021, the patient experienced DIZZINESS (She felt dizzy), HEADACHE (Later on same day, she had headache), NAUSEA (She had nausea) and RASH (She had Rash). On 20-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE SWELLING (After 5 days, her left arm at injection site swelled up), VACCINATION SITE PAIN (Injection site was painful, hard to touch, and itchy and warm) and VACCINATION SITE PRURITUS (Injection site was painful, hard to touch, and itchy and warm). On 29-Mar-2021, the patient experienced DISCOMFORT (As of now, she still doesn't feel 100%). At the time of the report, DISCOMFORT (As of now, she still doesn't feel 100%), DIZZINESS (She felt dizzy), VACCINATION SITE WARMTH (Injection site was painful, hard to touch, and itchy and warm), VACCINATION SITE INDURATION (Injection site was painful, hard to touch, and itchy and warm), HEADACHE (Later on same day, she had headache), NAUSEA (She had nausea), RASH (She had Rash), VACCINATION SITE SWELLING (After 5 days, her left arm at injection site swelled up), VACCINATION SITE PAIN (Injection site was painful, hard to touch, and itchy and warm) and VACCINATION SITE PRURITUS (Injection site was painful, hard to touch, and itchy and warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product included A-fib medication, anti-depressant and cholesterol medication. Treatment information was not provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chronic gastritis, Diarrhoea, Gastrointestinal motility disorder, Pain in extremity
Clinical narrative: diarrhea/loose bowels; intestinal pain (cramping); intestinal gas; intestinal movement; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness), DIARRHOEA (diarrhea/loose bowels), ABDOMINAL PAIN (intestinal pain (cramping)), CHRONIC GASTRITIS (intestinal gas) and GASTROINTESTINAL MOTILITY DISORDER (intestinal movement) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020 and Irritable bowel syndrome.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm soreness). On 25-Mar-2021, the patient experienced DIARRHOEA (diarrhea/loose bowels), ABDOMINAL PAIN (intestinal pain (cramping)), CHRONIC GASTRITIS (intestinal gas) and GASTROINTESTINAL MOTILITY DISORDER (intestinal movement). On 25-Mar-2021, PAIN IN EXTREMITY (arm soreness) had resolved. On 27-Mar-2021, ABDOMINAL PAIN (intestinal pain (cramping)) had resolved. At the time of the report, DIARRHOEA (diarrhea/loose bowels), CHRONIC GASTRITIS (intestinal gas) and GASTROINTESTINAL MOTILITY DISORDER (intestinal movement) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported        This case was linked to MOD-2021-061003 (Patient Link).
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Headache, Nausea
Clinical narrative: COVID-19; nausea; diarrhea; cough; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), PYREXIA (fever), NAUSEA (nausea), DIARRHOEA (diarrhea) and COUGH (cough) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided by reporter.     On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). On 14-Mar-2021, the patient experienced NAUSEA (nausea), DIARRHOEA (diarrhea) and COUGH (cough). On 16-Mar-2021, the patient experienced COVID-19 (COVID-19). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, COVID-19 (COVID-19), PYREXIA (fever), NAUSEA (nausea), DIARRHOEA (diarrhea), COUGH (cough) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were insulin, cholesterol and high blood pressure medication.   Reporter did not allow further contact
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: COVID-19; nausea; diarrhea; cough; headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), PYREXIA (fever), NAUSEA (nausea), DIARRHOEA (diarrhea) and COUGH (cough) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     no medical history was provided by reporter.     On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). On 14-Mar-2021, the patient experienced NAUSEA (nausea), DIARRHOEA (diarrhea) and COUGH (cough). On 16-Mar-2021, the patient experienced COVID-19 (COVID-19). The patient was treated with IBUPROFEN at a dose of UNK dosage form. At the time of the report, COVID-19 (COVID-19), PYREXIA (fever), NAUSEA (nausea), DIARRHOEA (diarrhea), COUGH (cough) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were insulin, cholesterol and high blood pressure medication.   Reporter did not allow further contact
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: half amount of dose administered; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (half amount of dose administered) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced UNDERDOSE (half amount of dose administered). On 28-Mar-2021, UNDERDOSE (half amount of dose administered) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Eating disorder, Feeling abnormal, Mobility decreased
Clinical narrative: Feeling abnormal; Hard time eating, getting up; Hard time eating, getting up; Loss of apetite; Severe diarrhea; COVID-19 symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of apetite), DIARRHOEA (Severe diarrhea), FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up) and MOBILITY DECREASED (Hard time eating, getting up) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020. Concurrent medical conditions included Kidney failure since June 2020, Dialysis, Diabetes and Hypertension.   On 23-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced SUSPECTED COVID-19 (COVID-19 symptoms). On 28-Mar-2021, the patient experienced DECREASED APPETITE (Loss of apetite) and DIARRHOEA (Severe diarrhea). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up) and MOBILITY DECREASED (Hard time eating, getting up). At the time of the report, DECREASED APPETITE (Loss of apetite), DIARRHOEA (Severe diarrhea), FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up), MOBILITY DECREASED (Hard time eating, getting up) and SUSPECTED COVID-19 (COVID-19 symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, SARS-CoV-2 test: positive (Positive) positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Significant Follow-up was received on 15-JULY-2021 and  outcome added.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Feeling abnormal; Hard time eating, getting up; Hard time eating, getting up; Loss of apetite; Severe diarrhea; COVID-19 symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of apetite), DIARRHOEA (Severe diarrhea), FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up) and MOBILITY DECREASED (Hard time eating, getting up) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in July 2020. Concurrent medical conditions included Kidney failure since June 2020, Dialysis, Diabetes and Hypertension.   On 23-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced SUSPECTED COVID-19 (COVID-19 symptoms). On 28-Mar-2021, the patient experienced DECREASED APPETITE (Loss of apetite) and DIARRHOEA (Severe diarrhea). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up) and MOBILITY DECREASED (Hard time eating, getting up). At the time of the report, DECREASED APPETITE (Loss of apetite), DIARRHOEA (Severe diarrhea), FEELING ABNORMAL (Feeling abnormal), EATING DISORDER (Hard time eating, getting up), MOBILITY DECREASED (Hard time eating, getting up) and SUSPECTED COVID-19 (COVID-19 symptoms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jan-2021, SARS-CoV-2 test: positive (Positive) positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Significant Follow-up was received on 15-JULY-2021 and  outcome added.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Inappropriate schedule of product administration, Rash erythematous, Vaccination site erythema, Vaccination site pain
Clinical narrative: Left arm feels like he is experiencing a "moderate sunburn"; A sore left arm; Red around the injection site; Tender area around the injection site; A headache that lasted 4 hours; 2nd dose was given less than 26 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose), RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), HEADACHE (A headache that lasted 4 hours), VACCINATION SITE PAIN (A sore left arm) and VACCINATION SITE ERYTHEMA (Red around the injection site) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pacemaker insertion (cardiac) in March 2018 and Stent insertion NOS in March 2018. Concurrent medical conditions included Blood calcium increased, Cardiac disorder, High cholesterol and Drug allergy. Concomitant products included VITAMINS NOS, ATORVASTATIN, SOTALOL, APIXABAN (ELIQUIS) and DILTIAZEM for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose) and HEADACHE (A headache that lasted 4 hours). On 28-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), VACCINATION SITE PAIN (A sore left arm), VACCINATION SITE ERYTHEMA (Red around the injection site) and VACCINATION SITE PAIN (Tender area around the injection site). On 23-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose was given less than 26 days after 1st dose) had resolved, HEADACHE (A headache that lasted 4 hours) outcome was unknown. At the time of the report, RASH ERYTHEMATOUS (Left arm feels like he is experiencing a "moderate sunburn"), VACCINATION SITE PAIN (A sore left arm), VACCINATION SITE ERYTHEMA (Red around the injection site) and VACCINATION SITE PAIN (Tender area around the injection site) outcome was unknown.            No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Joint swelling, Lymphadenopathy
Clinical narrative: swelling on collarbone; Swelling of lymph nodes under armpit; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, JOINT SWELLING (swelling on collarbone), LYMPHADENOPATHY (Swelling of lymph nodes under armpit) and FATIGUE (tiredness) outcome was unknown.            No concomitant medications were reported.   This case was linked to MOD-2021-035950 (Patient Link).   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in leg) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in leg). At the time of the report, PAIN IN EXTREMITY (pain in leg) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicines were not included,  Treatment drugs were not provided,  Action taken with mRNA-1273 in response to the event was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: had inmmediate tachycardia; This spontaneous case was reported by a physician and describes the occurrence of TACHYCARDIA (had immediate tachycardia) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concomitant products included Synthroid  for Hashimoto's tiroiditis, estradiol  for hormone replacement therapy and Lunesta  for sleep for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced TACHYCARDIA (had inmmediate tachycardia). On 22-Feb-2021, TACHYCARDIA (had inmmediate tachycardia) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to -MODERNATX, INC.-MOD-2021-060769 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up received on 21-MAY-2021 and outcome of the include recovering.; Sender's Comments:  -MODERNATX, INC.-MOD-2021-060769:Mother
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dissociation, Dizziness, Feeling abnormal, Hypoaesthesia
Clinical narrative: Numbness of face about 60%; Mild Tightness and pressure in chest; Dizziness; Feeling of outside of body with environment; Foggy brain; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of face about 60%), CHEST DISCOMFORT (Mild Tightness and pressure in chest), DIZZINESS (Dizziness), DISSOCIATION (Feeling of outside of body with environment) and FEELING ABNORMAL (Foggy brain) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced DISSOCIATION (Feeling of outside of body with environment) and FEELING ABNORMAL (Foggy brain). On 24-Mar-2021, the patient experienced HYPOAESTHESIA (Numbness of face about 60%), CHEST DISCOMFORT (Mild Tightness and pressure in chest) and DIZZINESS (Dizziness). At the time of the report, HYPOAESTHESIA (Numbness of face about 60%) and CHEST DISCOMFORT (Mild Tightness and pressure in chest) had resolved and DIZZINESS (Dizziness), DISSOCIATION (Feeling of outside of body with environment) and FEELING ABNORMAL (Foggy brain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the events was not taken.   Reporter did not allow further contact
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Vaccination site swelling
Clinical narrative: Stiffness in the injection arm (left); Swelling in the injection arm (left); This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness in the injection arm (left)) and VACCINATION SITE SWELLING (Swelling in the injection arm (left)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 101A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 08-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness in the injection arm (left)) and VACCINATION SITE SWELLING (Swelling in the injection arm (left)). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 08-Mar-2021, MUSCULOSKELETAL STIFFNESS (Stiffness in the injection arm (left)) and VACCINATION SITE SWELLING (Swelling in the injection arm (left)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: Tested positive for covid-19; Head cold; Congestion; This spontaneous case was reported by an other health care professional and describes the occurrence of NASOPHARYNGITIS (Head cold), NASAL CONGESTION (Congestion) and COVID-19 (Tested positive for covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced NASOPHARYNGITIS (Head cold) and NASAL CONGESTION (Congestion). On 24-Mar-2021, the patient experienced COVID-19 (Tested positive for covid-19). At the time of the report, NASOPHARYNGITIS (Head cold) and NASAL CONGESTION (Congestion) had not resolved and COVID-19 (Tested positive for covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: Injection site redder and larger by the day; Extremely painful; Injection arm 2 inchers larger than other arm; site temp 101; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE WARMTH (site temp 101), VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day) and VACCINATION SITE PAIN (Extremely painful) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE WARMTH (site temp 101) and VACCINATION SITE PAIN (Extremely painful). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day). At the time of the report, PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day) and VACCINATION SITE PAIN (Extremely painful) outcome was unknown and VACCINATION SITE WARMTH (site temp 101) was resolving.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: She began to develop a rash. It started on both arm with minimal hives, then, it was localized on the area around her knees seemed to have been going to the joints, then I wen to her hip area and worsened and then it went throughout her legs and was; This spontaneous case was reported by a consumer and describes the occurrence of RASH (She began to develop a rash. It started on both arm with minimal hives, then, it was localized on the area around her knees seemed to have been going to the joints, then I wen to her hip area and worsened and then it went throughout her legs and was) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension since 1998, Allergy to molds, Dust allergy, Adhesive tape allergy (Allergy to K-tape adhesive) and Latex allergy. Concomitant products included TAMOXIFEN from 15-Feb-2016 to 11-Mar-2021 for Breast cancer, UBIDECARENONE (COQ10 [UBIDECARENONE]) and RESVERATROL for Cardiovascular disorder NOS, OLMESARTAN and HCTZ for Hypertension, CALCIUM CITRATE;MAGNESIUM;VITAMIN D NOS for an unknown indication.   On 19-Jan-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021 at 9:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (She began to develop a rash. It started on both arm with minimal hives, then, it was localized on the area around her knees seemed to have been going to the joints, then I wen to her hip area and worsened and then it went throughout her legs and was). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at a dose of 1 and 4 per day. At the time of the report, RASH (She began to develop a rash. It started on both arm with minimal hives, then, it was localized on the area around her knees seemed to have been going to the joints, then I wen to her hip area and worsened and then it went throughout her legs and was) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Although patient was on Allegra the rash continued to advance for another 4 weeks despite of increase in  dose of Allegra.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow-up a received on 16-JUL-2021 and contains significant information updated physician contact details,patient demographics, past  medical history, concomitant and treatment medications and updated event outcome.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Chills; Fever (99.8 ºC); This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever (99.8 ºC)) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Cholesterol and Triglycerides.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever (99.8 ºC)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (Chills) and PYREXIA (Fever (99.8 ºC)) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include for high blood pressure, for cholesterol, for triglycerides.
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Cough, Dyspnoea, Illness, Pain
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of exacerbated asthma, cough (really bad chronic cough), dyspnea (hard to breath), illness (sick) and pain (hurting so bad) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 002D21A) for COVID-19 immunization. The occurrence of additional events detailed below. Concurrent medical conditions included asthma. On Mar 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 23, 2021, patient experienced exacerbated asthma, cough (really bad chronic cough), dyspnea (hard to breath), illness (sick), pain (hurting so bad) and pharyngeal swelling (lump under throat that was swollen). At the time of the report, exacerbated asthma), cough (really bad chronic cough), dyspnea (hard to breath), illness (sick), pain (hurting so bad) and pharyngeal swelling (lump under throat that was swollen) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Treatment included nebulizer every 3 hours and OTC cough medicine.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of exacerbated asthma, cough (really bad chronic cough), dyspnea (hard to breath), illness (sick) and pain (hurting so bad) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 002D21A) for COVID-19 immunization. The occurrence of additional events detailed below. Concurrent medical conditions included asthma. On Mar 23, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 23, 2021, patient experienced exacerbated asthma, cough (really bad chronic cough), dyspnea (hard to breath), illness (sick), pain (hurting so bad) and pharyngeal swelling (lump under throat that was swollen). At the time of the report, exacerbated asthma), cough (really bad chronic cough), dyspnea (hard to breath), illness (sick), pain (hurting so bad) and pharyngeal swelling (lump under throat that was swollen) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medications reported. Treatment included nebulizer every 3 hours and OTC cough medicine.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Headache, Influenza, Pain
Clinical narrative: "Worse flu she ever had"; Chills; Headache; Shortness of breath; Aches; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), PAIN (Aches), INFLUENZA ("Worse flu she ever had"), CHILLS (Chills) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 061A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction to antibiotics.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath), PAIN (Aches), CHILLS (Chills) and HEADACHE (Headache). On an unknown date, the patient experienced INFLUENZA ("Worse flu she ever had"). At the time of the report, DYSPNOEA (Shortness of breath), PAIN (Aches), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown and INFLUENZA ("Worse flu she ever had") had resolved.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Feeling abnormal, Flushing
Clinical narrative: Fever 100.8 degree, increased to 101.2 degree; Felt exhausted; Brain fog; Bad cramps both of my legs that brought me to the floor; Face and cheeks flushed; Chill; got up mid night and was cold, I was freezing; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (got up mid night and was cold, I was freezing), PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog) and MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma (asthma as a kid), Stroke (stroke two and half years ago), Rheumatic fever (rheumatic fever as 5 year old) and Diverticulosis. Concurrent medical conditions included Drug allergy (allergic to aspirin). Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy, POTASSIUM and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (got up mid night and was cold, I was freezing) and CHILLS (Chill). On 09-Mar-2021, the patient experienced PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog), MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor) and FLUSHING (Face and cheeks flushed). At the time of the report, NASOPHARYNGITIS (got up mid night and was cold, I was freezing), PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog), MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor), FLUSHING (Face and cheeks flushed) and CHILLS (Chill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 100.8 degree, increased to 101.2 degree (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication information is not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-039536 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-039536:DOSE 1
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Nasopharyngitis, Pyrexia
Clinical narrative: Fever 100.8 degree, increased to 101.2 degree; Felt exhausted; Brain fog; Bad cramps both of my legs that brought me to the floor; Face and cheeks flushed; Chill; got up mid night and was cold, I was freezing; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (got up mid night and was cold, I was freezing), PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog) and MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma (asthma as a kid), Stroke (stroke two and half years ago), Rheumatic fever (rheumatic fever as 5 year old) and Diverticulosis. Concurrent medical conditions included Drug allergy (allergic to aspirin). Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) for Anticoagulant therapy, POTASSIUM and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (got up mid night and was cold, I was freezing) and CHILLS (Chill). On 09-Mar-2021, the patient experienced PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog), MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor) and FLUSHING (Face and cheeks flushed). At the time of the report, NASOPHARYNGITIS (got up mid night and was cold, I was freezing), PYREXIA (Fever 100.8 degree, increased to 101.2 degree), FATIGUE (Felt exhausted), FEELING ABNORMAL (Brain fog), MUSCLE SPASMS (Bad cramps both of my legs that brought me to the floor), FLUSHING (Face and cheeks flushed) and CHILLS (Chill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Body temperature: 100.8 degree, increased to 101.2 degree (High) High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication information is not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-039536 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-039536:DOSE 1
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Fatigue, Headache, Nausea, Vertigo
Clinical narrative: The stomach is not normal; Vertigo; nausea; Fatigue/very fatigued; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (The stomach is not normal), VERTIGO (Vertigo), NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (The stomach is not normal), VERTIGO (Vertigo), NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches). At the time of the report, ABDOMINAL DISCOMFORT (The stomach is not normal) and VERTIGO (Vertigo) outcome was unknown and NAUSEA (nausea), FATIGUE (Fatigue/very fatigued) and HEADACHE (Headaches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Ibuprofen.  This case concerns a female of unknown age with unexpected abdominal discomfort and expected nausea and fatigue. Event onset with unknown latency. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-272419 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Follow up received: Significant FU-Patient Age provided, Vertigo and  headache added as adverse event as per phone call follow up reply; Sender's Comments: This case concerns a female of unknown age with unexpected abdominal discomfort and expected nausea and fatigue. Event onset with unknown latency. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.